Investors & Media

Jim Baker brings more than 15 years of experience as a biopharmaceutical communications leader building entrepreneurial, science-driven companies from discovery to commercialization, across global markets and through collaboration ecosystems. Since joining Blueprint Medicines as Vice President, Corporate Affairs in March 2017, Jim has overseen investor relations, corporate communications, global patient affairs, and internal communications. In January 2021, he was promoted to Senior Vice President, Corporate Affairs and, in January 2024, he joined the company’s executive team. During his tenure, Jim has played a key role in guiding the company’s evolution from an early development-stage enterprise to a fully integrated global biopharmaceutical company with two marketed medicines. He has helped the company raise more than $1.5 billion in capital, advanced pipeline strategy and programs as a member of the portfolio management team, and fostered and maintained a high-performance culture through periods of significant growth and change. Prior to joining us, Jim held roles of increasing responsibility in investor relations, corporate communications, new product planning and market development, and patient advocacy at Biogen, Sarepta Therapeutics, PTC Therapeutics, and Idera Pharmaceuticals. Jim received dual B.A. degrees in journalism and political science from the University of Southern California, where he was a Reserve Officer Training Corps scholar, and completed his military service as a Captain in the U.S. Army Signal Corps.